Cargando…
Elevated Soluble Suppressor of Tumorigenicity 2 Predict Hospital Admissions Due to Major Adverse Cardiovascular Events (MACE)
The role of soluble suppression of tumorigenicity (sST2) as a biomarker in predicting clinical outcomes in patients with cardiovascular diseases (CVD) has not been fully elucidated. In this study, we sought to determine the relationship between sST2 levels and any unplanned hospital readmissions due...
Autores principales: | Chen, Dongqing, Untaru, Rossana, Stavropoulou, Glykeria, Assadi-Khansari, Bahador, Kelly, Conagh, Croft, Amanda J., Sugito, Stuart, Collins, Nicholas J., Sverdlov, Aaron L., Ngo, Doan T. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142832/ https://www.ncbi.nlm.nih.gov/pubmed/37109127 http://dx.doi.org/10.3390/jcm12082790 |
Ejemplares similares
-
Association of Circulating Plasma Secreted Frizzled-Related Protein 5 (Sfrp5) Levels with Cardiac Function
por: Kelly, Conagh J., et al.
Publicado: (2023) -
Suboptimal Use of Cardioprotective Medications in Patients With a History of Cancer
por: Untaru, Rossana, et al.
Publicado: (2020) -
Overexpression of Mitochondrial Catalase within Adipose Tissue Does Not Confer Systemic Metabolic Protection against Diet-Induced Obesity
por: Croft, Amanda J., et al.
Publicado: (2023) -
Early access to a cardio-oncology clinic in an Australian context: a qualitative exploration of patient experiences
por: White, Jennifer, et al.
Publicado: (2022) -
Vitamin D supplementation lowers thrombospondin-1 levels and blood pressure in healthy adults
por: Amarasekera, Anjalee T., et al.
Publicado: (2017)